| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/24/2008 | CA2657850A1 Novel pyridazine derivatives |
| 01/24/2008 | CA2657821A1 Aza-peptide protease inhibitors |
| 01/24/2008 | CA2657776A1 Triazolyl phenyl benzenesulfonamides |
| 01/24/2008 | CA2657745A1 Pyrimidine derivatives and their use as pesticides |
| 01/23/2008 | EP1880995A1 Method for producing indole derivative having piperidine ring |
| 01/23/2008 | EP1880994A1 Crystal of indole derivative having piperidine ring and process for production thereof |
| 01/23/2008 | EP1880993A1 Nitrogen-containing heterocyclic compound |
| 01/23/2008 | EP1879883A2 Stilbene derivatives and methods of inhibiting cancer cell growth and microbial growth |
| 01/23/2008 | EP1879882A1 3 -m0n0- and 3 , 5-disubstituted piperidine derivatives as renin inhibitors |
| 01/23/2008 | EP1879881A2 Inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
| 01/23/2008 | EP1879878A2 New heterocyclylethylcarboxamide derivatives |
| 01/23/2008 | EP1879873A1 Neurotherapeutic azole compounds |
| 01/23/2008 | EP1879580A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
| 01/23/2008 | EP1673086B1 4-aminoquinoline-3-carboxamide derivatives as pde4 inhibitors |
| 01/23/2008 | EP1667635A4 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 01/23/2008 | EP1569934B1 Cyclopropyl compounds as ccr5 antagonists |
| 01/23/2008 | EP1501801B1 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases |
| 01/23/2008 | EP1432313B1 N-thio-nicotinamide derivatives and related compounds for use as pesticides |
| 01/23/2008 | EP1339687B1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 01/23/2008 | EP1330451B1 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 01/23/2008 | EP1257547B1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 01/23/2008 | EP1105730B1 Enzyme inhibition immunoassay |
| 01/23/2008 | CN101111493A 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
| 01/23/2008 | CN101111492A 吲哚衍生物 Indole derivatives |
| 01/23/2008 | CN101111490A 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 01/23/2008 | CN101111489A Amino-pyridines as inhibitors of beta-secretase |
| 01/23/2008 | CN101108848A Furoquinoline compound and application of the same in manufacturing anti-virus medicament |
| 01/23/2008 | CN101108847A (+) doxazosin mesylate, method of manufacturing the same and use thereof |
| 01/23/2008 | CN100363840C Organophotoreceptor with a charge transport material having two epoxidated-hydrazone groups |
| 01/23/2008 | CN100363348C PgD2 receptor antagonists for the treatment of inflammatory diseases |
| 01/22/2008 | US7321063 Sulfonamide inhibitors of aspartyl protease |
| 01/22/2008 | US7321050 and stilbene oxides; 3,5-dihydroxy-4-isopropylstilbene for example; treating various immune, inflammatory, and autoimmune diseases |
| 01/22/2008 | US7320995 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole |
| 01/22/2008 | US7320993 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents |
| 01/22/2008 | US7320986 for treating cancer; 4'-(6,7-dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)-1,1'-biphenyl-4-yl 1,4'-bipiperidine-1'-carboxylate for example |
| 01/22/2008 | US7320983 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 01/22/2008 | US7320982 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-β 1 |
| 01/22/2008 | US7320972 Hypercholesterolemia, cholesterol-associated benign and malignant tumors; hyperlipidemia, arteriosclerosis, and sitosterolemia; 6) (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(2',3',4'-trimethoxybiphenyl-4-yl)azetidin-2-one |
| 01/22/2008 | US7320849 Organophotoreceptor with a charge transport material having two epoxidated-hydrazone groups |
| 01/22/2008 | CA2420999C 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 01/22/2008 | CA2374362C Urea derivatives as hiv aspartyl protease inhibitors |
| 01/22/2008 | CA2293553C Aminooxyamide tricyclic inhibitors of farnesyl-protein transferase |
| 01/22/2008 | CA2281721C Phthalazines with angiogenesis inhibiting activity |
| 01/22/2008 | CA2214321C Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 01/17/2008 | WO2008008493A2 Alkyne-substituted pyridone compounds and methods of use |
| 01/17/2008 | WO2008008020A1 3-oxoisoindoline-1-carboxamide derivatives as analgesic agents |
| 01/17/2008 | WO2008007780A1 Pentadienamide derivative |
| 01/17/2008 | WO2008007169A1 An enantioselective synthesis of pyrrolidine-substituted flavones |
| 01/17/2008 | WO2008006873A1 Fungicide hydroximoyl-tetrazole derivatives |
| 01/17/2008 | WO2008006790A1 Indole compounds |
| 01/17/2008 | WO2008006702A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 01/17/2008 | WO2008006627A1 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| 01/17/2008 | WO2008006583A1 Pyrimidine derivatives as alk-5 inhibitors |
| 01/17/2008 | WO2008006499A2 Substituted furyl sulfonylamino(thio)carbonyl triazoline(thi)ones |
| 01/17/2008 | WO2008006287A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | WO2007115265A3 Reagents useful for synthesizing rhodamine-labeled oligonucleotides |
| 01/17/2008 | WO2007113202A8 Piperazine derivatives as growth hormone secretagogue (ghs) receptor agonists |
| 01/17/2008 | WO2007019080A3 Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/17/2008 | WO2006056930A3 Novel 4 -aminopiperidine derivatives as plasmepsin ii inhibitors |
| 01/17/2008 | US20080015354 Novel Process For The Preparation Of 2H-Chromenes |
| 01/17/2008 | US20080015245 1,5-diarylpyrrole derivatives, preparation method thereof and application of same in therapeutics |
| 01/17/2008 | US20080015243 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 01/17/2008 | US20080015242 Use of N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydroxyethyl]phenyl]methanesulfonamide or salt for treating diabetes, obesity, hyperlipidemia and urinary incontinence; drug interaction side effect reduction |
| 01/17/2008 | US20080015235 Histamine H3 Receptor Inhibitors, Preparation and Therapeutic Uses |
| 01/17/2008 | US20080015232 Schweinfurthin analogues |
| 01/17/2008 | US20080015226 Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors |
| 01/17/2008 | US20080015222 New Heterocyclic Amides |
| 01/17/2008 | US20080015220 Biphenyl-2-ylcarbamic acid 1-{7-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]heptyl}piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, chronic obstructive pulmonary disease and asthma |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080014189 Diaminotriazoles useful as inhibitors of protein kinases |
| 01/17/2008 | US20080014173 N-(4,6-dimethyl-2-pyridinyl)-L-valyl- N-(1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-4-((6-methoxy-1-isoquinolinyl)carboxy)-L-prolinamide; viricide; synergistic with other active ingredients |
| 01/17/2008 | DE102006032824A1 Substituierte Indazole Substituted indazoles |
| 01/17/2008 | CA2659590A1 Irreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | CA2658215A1 An enantioselective synthesis of pyrrolidines-substituted flavones |
| 01/17/2008 | CA2658097A1 Pentadienamide derivatives |
| 01/17/2008 | CA2657598A1 Substituted furyl sulfonylamino(thio)carbonyl triazoline(thi)ones |
| 01/17/2008 | CA2657227A1 Pyrimidine derivatives as alk-5 inhibitors |
| 01/17/2008 | CA2657078A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 01/17/2008 | CA2657006A1 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| 01/17/2008 | CA2653589A1 Fungicide hydroximoyl-tetrazole derivatives |
| 01/16/2008 | EP1878733A1 Pyrimidine derivatives as ALK-5 inhibitors |
| 01/16/2008 | EP1878728A2 Derivatives of piperazine and higher homologues thereof for the treatment of inflammation-related disorders |
| 01/16/2008 | EP1878725A2 Pyrimidine derivatives and their use as CB2 modulators |
| 01/16/2008 | EP1878723A1 N-[(1,5-diphenyl-1H-pyrazol-3-yl)methyl]sulfonamide derivatives antagonists of the CB1 cannabinoids receptors |
| 01/16/2008 | EP1877403A1 Mono-lysine salts of azole compounds |
| 01/16/2008 | EP1877393A2 Processes for preparing darifenacin hydrobromide |
| 01/16/2008 | EP1877385A1 Pyrimidines and pyrazines useful as modulators of ion channels |
| 01/16/2008 | EP1877378A2 Oxindole compounds and their uses as therapeutic agents |
| 01/16/2008 | EP1877376A1 Novel compounds for treating inflammatory diseases |
| 01/16/2008 | EP1877364A1 Phenylacetylene derivatives having mglur5 receptor affinity |
| 01/16/2008 | EP1713778B1 Benzazepine derivatives as histamine h3 antagonists |
| 01/16/2008 | EP1601659B1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands |
| 01/16/2008 | EP1458684B1 Therapeutic heterocycles as bradykinin b2 receptor antagonists |
| 01/16/2008 | EP1451154B1 Inhibitors of cytosolic phospholipase a2 |
| 01/16/2008 | EP1354020B1 Novel red fluorescent material and organic electroluminescent device containing same |
| 01/16/2008 | EP1317432B1 Piperidine derivatives for use as 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 01/16/2008 | EP1122242B1 Cyanophenyl derivatives |
| 01/16/2008 | EP0620003B1 Vasopressin antagonist and oxytocin antagonist |
| 01/16/2008 | CN101107233A 1H-imidiazole derivatives as cannabinoid CB2 receptor modulators |
| 01/16/2008 | CN101107231A Imidazole and benzimidazole derivatives useful as histamine H3 antagonists |